CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

CL-387785 5mg  | ≥98%

CSNpharm

CL-387785 irreversibly inhibits EGFR with IC50 of 370 pM and shows inhibition of the functional effects of mutations T790M.

More Information Supplier Page

CL-387785 10mg  | ≥98%

CSNpharm

CL-387785 irreversibly inhibits EGFR with IC50 of 370 pM and shows inhibition of the functional effects of mutations T790M.

More Information Supplier Page

CL-387785 2mg  | ≥98%

CSNpharm

CL-387785 irreversibly inhibits EGFR with IC50 of 370 pM and shows inhibition of the functional effects of mutations T790M.

More Information Supplier Page

CL2A-SN-38 1mg  | ≥98%

CSNpharm

CL2A-SN38 is a SN38 derivative with a peptide-linker which can easily react with antibody to form an antibody-drug conjugate (ADC). CL2A-SN-38 is composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody drug conjugate (ADC). CL2A-SN-38 provides significant and specific antitumor effects against a range of human solid […]

More Information Supplier Page

CL2A-SN-38 10mg  | ≥98%

CSNpharm

CL2A-SN38 is a SN38 derivative with a peptide-linker which can easily react with antibody to form an antibody-drug conjugate (ADC). CL2A-SN-38 is composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody drug conjugate (ADC). CL2A-SN-38 provides significant and specific antitumor effects against a range of human solid […]

More Information Supplier Page

CL2A-SN-38 5mg  | ≥98%

CSNpharm

CL2A-SN38 is a SN38 derivative with a peptide-linker which can easily react with antibody to form an antibody-drug conjugate (ADC). CL2A-SN-38 is composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody drug conjugate (ADC). CL2A-SN-38 provides significant and specific antitumor effects against a range of human solid […]

More Information Supplier Page

Cladribine 50mg  | ≥99%

CSNpharm

Cladribine is an adenosine deaminase inhibitor used to treat hairy cell leukemia and multiple sclerosis. For U266, RPMI8226, and MM1.S cells, its IC50 are approximately 2.43 μM, 0.75 μM, and 0.18 μM, respectively.

More Information Supplier Page

Cladribine 100mg  | ≥99%

CSNpharm

Cladribine is an adenosine deaminase inhibitor used to treat hairy cell leukemia and multiple sclerosis. For U266, RPMI8226, and MM1.S cells, its IC50 are approximately 2.43 μM, 0.75 μM, and 0.18 μM, respectively.

More Information Supplier Page

Cladribine 10mg  | ≥99%

CSNpharm

Cladribine is an adenosine deaminase inhibitor used to treat hairy cell leukemia and multiple sclerosis. For U266, RPMI8226, and MM1.S cells, its IC50 are approximately 2.43 μM, 0.75 μM, and 0.18 μM, respectively.

More Information Supplier Page

Clebopride Malate 100mg  | ≥99%

CSNpharm

Clebopride malate, with antiemetic and prokinetic properties, is a dopamine antagonist drug used to treat gastrointestinal dysfunction.

More Information Supplier Page

Clebopride Malate 5mg  | ≥99%

CSNpharm

Clebopride malate, with antiemetic and prokinetic properties, is a dopamine antagonist drug used to treat gastrointestinal dysfunction.

More Information Supplier Page

Clebopride Malate 50mg  | ≥99%

CSNpharm

Clebopride malate, with antiemetic and prokinetic properties, is a dopamine antagonist drug used to treat gastrointestinal dysfunction.

More Information Supplier Page

Clebopride Malate 10mg  | ≥99%

CSNpharm

Clebopride malate, with antiemetic and prokinetic properties, is a dopamine antagonist drug used to treat gastrointestinal dysfunction.

More Information Supplier Page

Clevidipine 25mg  | ≥99%

CSNpharm

Clevidipine is a short-acting dihydropyridine calcium channel antagonist with IC50 of 7.1 nM, it’s under development for treatment of perioperative hypertension.

More Information Supplier Page

Clevidipine 100mg  | ≥99%

CSNpharm

Clevidipine is a short-acting dihydropyridine calcium channel antagonist with IC50 of 7.1 nM, it’s under development for treatment of perioperative hypertension.

More Information Supplier Page

Clevidipine 10mg  | ≥99%

CSNpharm

Clevidipine is a short-acting dihydropyridine calcium channel antagonist with IC50 of 7.1 nM, it’s under development for treatment of perioperative hypertension.

More Information Supplier Page

Clevidipine 50mg  | ≥99%

CSNpharm

Clevidipine is a short-acting dihydropyridine calcium channel antagonist with IC50 of 7.1 nM, it’s under development for treatment of perioperative hypertension.

More Information Supplier Page

Clindamycin HCl 25mg  | ≥99%

CSNpharm

Clindamycin HCl is an antibiotic useful for the treatment of a number of bacterial infections, largely replaced lincomycin due to an improved side effect profile.

More Information Supplier Page

Clindamycin HCl 100mg  | ≥99%

CSNpharm

Clindamycin HCl is an antibiotic useful for the treatment of a number of bacterial infections, largely replaced lincomycin due to an improved side effect profile.

More Information Supplier Page

Clinofibrate 50mg  | ≥99%

CSNpharm

Clinofibrate is a HMG-CoA reductase inhibitor with IC50 value of 470 μM which can reduce plasma cholesterol levels and shows antihyperlipidemic effects.

More Information Supplier Page

Clinofibrate 5mg  | ≥99%

CSNpharm

Clinofibrate is a HMG-CoA reductase inhibitor with IC50 value of 470 μM which can reduce plasma cholesterol levels and shows antihyperlipidemic effects.

More Information Supplier Page

Clinofibrate 250mg  | ≥99%

CSNpharm

Clinofibrate is a HMG-CoA reductase inhibitor with IC50 value of 470 μM which can reduce plasma cholesterol levels and shows antihyperlipidemic effects.

More Information Supplier Page

Clinofibrate 10mg  | ≥99%

CSNpharm

Clinofibrate is a HMG-CoA reductase inhibitor with IC50 value of 470 μM which can reduce plasma cholesterol levels and shows antihyperlipidemic effects.

More Information Supplier Page

Clinofibrate 100mg  | ≥99%

CSNpharm

Clinofibrate is a HMG-CoA reductase inhibitor with IC50 value of 470 μM which can reduce plasma cholesterol levels and shows antihyperlipidemic effects.

More Information Supplier Page